Regeneron Pharmaceuticals to buy bankrupt 23andMe in $256M deal

  • Genetic testing company 23andMe filed for Chapter 11 bankruptcy protection in March. Regeneron Pharmaceuticals announced it would buy "substantially all" of 23andMe's assets.